Osteopontin is required for full expression of the transformed phenotype by the ras oncogene

British Journal of Cancer

Volumn 83, Issue 2, 2000, Pages 156-163

  Wu, Y ^a   Denhardt, D T ^a   Rittling, S R ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Anchorage independence; Immortalization; Integrins; ras; Tumorigenesis

Indexed keywords

INTEGRIN; OSTEOPONTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL STRAIN 3T3; COLONY FORMATION; CONTROLLED STUDY; GENETIC TRANSFECTION; GENETIC TRANSFORMATION; MOUSE; NONHUMAN; ONCOGENE RAS; PHENOTYPE; PRIORITY JOURNAL;

EID: 0034085531     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1200     Document Type: Article

References (60)

1. 1 integrin. J Cell Sci 111: 1165-1174
2. Behrend EI, Craig AM, Wilson SM, Denhardt DT and Chambers AF (1994) Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA. Cancer Res 54: 832-837
3. Bellahcène A and Castronovo V (1995) Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer. Am J Pathol 146: 95-100
4. 3 for angiogenesis. Science 264: 569-571
5. 3 antagonists promote 1 regression by inducing apoptosis of angiogenic blood vessels. Cell 79: 1157-1164
6. Brown LF, Papadopoulous-Sergiou A, Berse B, Manseau EJ, Tognazzi K, Perruzzi CA, Dvorak HF and Senger DR (1994) Osteopontin expression and distribution in human carcinomas. Am J Pathol 145: 610-623
7. Casson AG, Wilson SM, McCart JA, O'Malley FP, Ozcelik H, Tsao MS and Chambers AF (1997) ras mutation and expression of the ras-regulated genes osteopontin and cathepsin L in human esophageal cancer. Int J Cancer 72: 739-745
8. Chambers AF, Denhardt DT and Wilson SM (1990) RAS-transformed NIH3T3 cell lines, selected for metastatic ability in chick embryos, have increased proportions of p21-expressing cells and are metastatic in nude mice. Invasion Metastasis 10: 225-240
9. Chambers AF, Behrend EI, Wilson SM and Denhardt DT (1992a) Induction of expression of osteopontin (OPN, secreted phosphoprotein) in metastatic, ras-transformed NIH-3T3 cells. Anticancer Res 12: 43-48
10. Chambers AF, Colella R, Denhardt DT and Wilson SM (1992b) Increased expression of cathepsins L and B and decreased activity of their inhibitors in metastatic, ras-transformed NIH 3T3 cells. Mol Carcinog 5: 238-245
11. Chambers AF, Hota C and Prince CW (1993) Adhesion of metastatic, ras-transformed NIH 3T3 cells to osteopontin, fibronectin, and laminin. Cancer Res 53: 701-706
12. Chen H, Ke Y, Oates AJ, Barraclough R and Rudland PS (1997) Isolation of and effector for metastasis-inducing DNAs from a human metastatic carcinoma cell line. Oncogene 14: 1581-1588
13. Clezardin P (1998) Recent insights into the role of integrins in cancer metastasis. Cell Mol Life Sci 54: 541-548
14. Craig AM, Bowden GT, Chambers AF, Spearman MA, Greenberg AH, Wright JA, McLeod M and Denhardt DT (1990) Secreted phosphoprotein mRNA is induced during multistage carcinogenesis in skin and correlates with the metastatic potential of murine fibroblasts. Int J Cancer 46: 133-137
15. Crawford HC, Matrisian LM and Liaw L (1998) Distinct roles of osteopontin in host defense activity and tumour survival during squamous cell carcinoma progression in vivo. Cancer Res 58: 5206-5215
16. 1 and potential roles for this integrin-ligand interaction in kidney morphogenesis. Mol Biol Cell 9: 1425-1435
17. Denhardt DT and Chambers AF (1994) Overcoming obstacles to metastasis - a defense against host defenses: Osteopontin (OPN) as a shield against attack by cytotoxic host cells. J Cell Biochem 56: 48-51
18. Feng B, Rollo EE and Denhardt DT (1995) Osteopontin (OPN) may facilitate metastasis by protecting cells from macrophage NO-mediated cytotoxicity: evidence from cell lines down-regulated for OPN expression. Clin Exp Metastasis 13: 453-462
19. Freedman VH and Shin SI (1974) Cellular tumourigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell 3: 355-359
20. Frisch SM and Ruoslahti E (1997) Integrins and anoikis. Curr Opin Cell Biol 9: 701-706
21. Gardner HAR, Berse B and Senger DR (1994) Specific reduction in osteopontin synthesis by antisense RNA inhibits the tumourigenicity of transformed Ratl fibroblasts. Oncogene 9: 2321-2326
22. Giachelli CM, Lombardi D, Johnson RJ, Murry CE and Almeida M (1998) Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol 152: 353-358
23. Goligorsky MS, Noiri E, Kessler H and Romanov V (1997) Therapeutic potential of RGD peptides in acute renal injury. Kidney Int 51: 1487-1492
24. Gossen M and Bujard H (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89: 5547-5551
25. Guo X, Zhang YP, Mitchell DA, Denhardt DT and Chambers AF (1995) Identification of a ras-activated enhancer in the mouse osteopontin promoter and its interaction with a putative ETS-relaled transcription factor whose activity correlates with the metastatic potential of the cell. Mol Cell Biol 15: 476-487
26. Hirota S, Ito A, Nagoshi J, Takeda M, Kurata A, Takatsuka Y, Kohri K, Nomura S and Kitamura Y (1995) Expression of bone matrix messenger ribonucleic acids in human breast cancers. Possible involvement of osteopontin in development of calcifying foci. Lab Invest 72: 64-69
27. 3. J Biol Chem 270: 9917-9925
28. 5. J Biol Chem 270: 26232-26238
29. Hwang SM, Lopez CA, Heck DE, Gardner CR, Laskin DL, Laskin JD and Denhardt DT (1994) Osteopontin inhibits induction of nitric oxide synthase gene expression by inflammatory mediators in mouse kidney epithelial cells. J Biol Chem 269: 711-715
30. Hynes RO (1992) Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69: 11-25
31. Juliano RL (1994) Signal transduction by integrins and its role in the regulation of tumour growth. Cancer Metastasis Rev 13: 25-30
32. Katagiri YU, Sleeman J, Fujii H, Herrlich P, Hotta H, Tanaka K, Chikuma S, Yagita H, Okumura K, Murakami M, Saiki I, Chambers AF and Uede T (1999) CD-44 variants but not CD-44s cooperate with beta-1 containing integrins to permit cells to bind to osteopontin independently of arginine-glycine aspartic acid, thereby stimulating cell motilily and chemotaxis. Cancer Res 59: 219-226
33. 3 in smooth muscle migration to osteopontin in vitro. J Clin Invest 95: 713-724
34. Liaw L, Birk DE, Ballas CB, Whitsitt JS, Davidson JM and Hogan BLM (1998) Altered wound healing in mice lacking a functional osteopontin gene (sppl). J Clin Invest 101: 1468-1478
35. Malyankar UM, Rittling SR, Connor A and Denhardt DT (1994) The mitogen-regulated protein/proliferin transcript is degraded in primary mouse embryo fibroblast but not 3T3 nuclei: altered RNA processing correlates with immortalization. Proc Natl Acad Sci USA 91: 335-339
36. Montgomery AM, Reisfeld RA and Cheresh DA (1994) Integrin alpha v beta 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proc Natl Acad Sci USA 91: 8856-8860
37. Noiri E, Dickman K, Miller F, Romanov G, Romanov V, Shaw R, Rittling SR, Denhardt DT and Goligorsky MS (1999) Acute renal ischemia in mice with a targeted disruption of the osteopontin gene: link to nitric oxide-induced injury. Kidney Int 56: 74-83
38. Oates AJ, Barraclough R and Rudland PS (1996) The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model. Oncogene 13: 97-104
39. Renshaw MW, Ren XD and Schwartz MA (1997) Growth factor activation of MAP kinase requires cell adhesion. EMBO J 18: 5592-5599
40. Rittling SR (1996) Clonal nature of spontaneously immortalized 3T3 cells. Exp Cell Res 229: 7-13
41. Rittling SR and Novick KW (1997) Osteopontin expression in mammary gland development and tumorigenesis. Cell Growth Differ 8: 1061-1069
42. Rittling SR and Feng F (1998) Detection of mouse osteopontin by western blotting. Biochem Biophys Res Commun 250: 287-292
43. Rittling SR and Denhardt DT (1999) Osteopontin (OPN) function in pathology: lessons from OPN-deficient mice. Experimental Nephrology 7: 103-113
44. Rittling SR, Matsumoto HN, McKee MD, Nanci A, An XR, Novick KE, Kowalski AJ, Noda M and Denhardt DT (1998) Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J Bone Miner Res 13: 1101-1111
45. Rollo EE, Laskin DL and Denhardt DT (1996) Osteopontin inhibits nitric oxide production and cytotoxicity by activated RAW 264.7 macrophages. J Leukoc Biol 60: 397-404
46. Ruoslahti E (1997) Integrins as signaling molecules and targets for tumour therapy. Kidney Int 51: 1413-1417
47. 3 integrin induced endothelial cell survival. J Cell Biol 141: 1083-1093
48. Schwartz MA (1997) Integrins, oncogenes and anchorage independence. J Cell Biol 139: 575-578
49. Senger DR, Asch BB, Smith BD, Perruzzi CA and Dvorak HF (1983) A secreted phosphoprotein marker for neoplastic transformation of both epithelial and fibroblastic cells. Nature 302: 714-715
50. Senger DR, Perruzzi CA, Gracey CF, Papadopoulous A and Tenen DG (1988) Secreted phospohoproteins associated with neoplastic transformation: close homology with plasma proteins cleaved during blood coagulation. Cancer Res 48: 5770-5774
51. Senger DR, Perruzzi CA, Papadopoulous-Sergiou A and Van De Water L (1994) Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain. Mol Biol Cell 5: 565-574
52. 3 integrin, osteopontin, and thrombin. Am J Pathol 149: 293-305
53. Singh RP, Patarca R, Schwartz J, Singh P and Cantor H (1990) Definition of a specific interaction between the early T lymphocyte activation 1 (Eta-1) protein and murine macrophages in vitro and its effect upon macrophages in vivo. J Exp Med 171: 1931-1942
54. 1, integrin. J Biol Chem 271: 28485-28491
55. Somerman MJ, Prince CW, Sauk JJ, Foster RA and Butler WT (1987) Cell attachment activity of the 44 kilodalton bone phosphoprotein is not restricted to bone cells. Matrix 9: 49-54
56. 5 during angiogenesis. J Clin Invest 98: 426-433
57. Su L, Mukherjee AB and Mukherjee BB (1995) Expression of antisense osteopontin mRNA inhibits tumour promoter-induced neoplastic transformation of mouse JB6 epidermal cells. Oncogene 10: 2163-2169
58. Tuck AB, O'Malley FP, Singhal H, Tonkin KS, Kerkvliet N, Saad Z, Doig GS and Chambers AF (1998) Osteopontin expression in a group of lymph node negative breast cancer patients. Int J Cancer 79: 502-508
59. Weber GF, Ashkar S, Glimcher MJ and Cantor H (1996) Receptor-ligand interaction between CD44 and osteopontin (ETA-1). Science 271: 509-512
60. 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc Natl Acad Sci USA 92: 6161-6165